英文别名 |
Prost-5-en-1-oic acid,9,11-dihydroxy-15-oxo-, (5Z,9a,11a)-;13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA;13,14-dihydro-15-keto Prostaglandin F2α;13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard;13,14-dihydro-15-keto PGF2a;13,14-Dihydro-15-ketodinoprost;13,14-dihydro-15-keto-PGF2alpha;13,14-Dihydro-15-ketoprostaglandin f;13,14-Dihydro-15-oxoprostaglandin f;15-Keto-13,14-dihydro-pgf2alpha;PGFM;Prostaglandin FM;13,14-DIHYDRO-15-KETO-PGF2a;13,14-dihydro-15-keto Prostaglandin F2alpha Lipid Maps(R) MS Standard;15-keto-dihydro-PGF2alpha;SR-01000946490;Q27070766;A;13,14-dihydro-15-keto PGF2alpha;CS-0059317;13,14-Dihydro-15-keto-PGF2;CHEBI:63976;VKTIONYPMSCHQI-XAGFEHLVSA-N;15-Keto-13,14-dihydroprostaglandin F2-alpha;(5Z,9alpha,11 alpha)-9,11-Dihydroxy-15-oxoprost-5-en-1-oic acid;DTXSID701019118;SMR000058898;HMS3648D18;(5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid;13,14-dihydro-15-keto-Prostaglandin F2alpha;NCGC00161288-01;13,14-Dihydro-15-keto-prostaglandin F2 alpha;Pulmonary metabolite-pgf2alpha;HY-113208;Prost-5-en-1-oic acid, 9,11-dihydroxy-15-oxo-, (5Z,9alpha,11alpha)-;13,14-dihydro-15-keto-Prostaglandin F2a;13,14-Dihydro-15-ketoPGF2alpha;GTPL1901;PD021301;SR-01000946490-1;27376-76-7;15-Keto-13,14-dihydro-prostaglandin F2alpha;Dhk-pgf2alpha;BML1-G01;SCHEMBL23406932;15-Keto-13,14-dihydroprostaglandin F2alpha;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid;MLS000028871;J-016752;13,14-dihydro-15-keto-PGF2 alpha;13,14-Dihydro-15-ketoprostaglandin F2alpha;LMFA03010027;9S,11S-dihydroxy-15-oxo-5Z-prostenoic acid;(5Z,9 alpha, 11 alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid;15-K-DH-PGF(2alpha);(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl)hept-5-enoic acid |